PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'School of Chemistry, The University of Sydney, Sydney, NSW 2006, Australia.\', \'Tuberculosis Research Program Centenary Institute, The University of Sydney, Camperdown, NSW 2006, Australia.\', \'Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW 2006, Australia.\', \'Tuberculosis Research Program Centenary Institute, The University of Sydney, Camperdown, NSW 2006, Australia; w.britton@centenary.org.au richard.payne@sydney.edu.au.\', \'Department of Clinical Immunology, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia.\', \'School of Chemistry, The University of Sydney, Sydney, NSW 2006, Australia; w.britton@centenary.org.au richard.payne@sydney.edu.au.\', \'Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, The University of Sydney, Sydney, NSW 2006, Australia.\']
?:citedBy
  • -1
?:creator
?:doi
  • e201373011810.1073/pnas.2013730118
?:doi
?:hasPublicationType
?:journal
  • Proceedings of the National Academy of Sciences of the United States of America
is ?:pmid of
?:pmid
?:pmid
  • 33468674
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.092
?:rankingScore_hIndex
  • 675
is ?:relation_isRelatedTo_publication of
?:title
  • Synthetic protein conjugate vaccines provide protection against Mycobacterium tuberculosis in mice.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all